Abstract:Information about the mechanisms that generate mutations in eukaryotes is likely to be useful for understanding human health concerns, such as genotoxicity and cancer. Eukaryotic mutagenesis is largely the outcome of attacks by endogenous and environmental agents. Except for DNA repair, cell cycle checkpoints and DNA damage avoidance, cells have also evolved DNA damage tolerance mechanism, by which lesion-targeted mutation might occur in the genome during replication by specific DNA polymerases to bypass the lesions (translesion DNA synthesis, TLS), or mutation on undamaged DNA templates (untargeted mutation) might be induced. DNA polymerase zeta (pol zeta), which was found firstly in budding yeast Saccharomyces cerevisiae and consists of catalytic subunit scRev3 and stimulating subunit scRev7, has received more attention in recent years. Pol zeta is a member of DNA polymerase delta subfamily, which belongs to DNA polymerase B family, and exists in almost all eukaryotes. Human homolog of the scRev3 gene is located in chromosome region 6q21, and the mouse equivalent maps to chromosome 10, distal to the c-myb gene and close to the Macs gene. Alternative splicing, upstream out-of frame ATG can be found in yeast scRev3, mouse and human homologs. Furthermore, the sequence from 253-323 immediate upstream of the AUG initiator codon has the potential to form a stem-loop hairpin secondary structure in REV3mRNA, suggesting that human REV3 protein may be expressed at low levels in human cells under normal growth conditions. The functional domain analysis showed that yeast Rev3-980 tyrosine in conserved region II is at the polymerase active site. Human REV3 amino acid residues 1 776-2 195 provide a REV7 binding domain, and REV7 amino acid residues 1-211 provide a bind domain for REV1, REV3 and REV7 itself More interestingly, REV7 interacts with hMAD2 and therefore might function in the cell cycle control by affecting the activation of APC (anaphase promoting complex). Currently it has been known that pol zeta is involved in most spontaneous mutation, lesion-targeted mutation via TLS, chemical carcinogen induced untargeted mutation and somatic hypermutation of antibody genes in mammalian. In TLS pathway, pol zeta acts as a "mismatch extender" with combination of other DNA polymerases, such as pol iota. Unlike in yeast, it was found that pol zeta also functioned in mouse embryonic development more recently. It was hypothesized that the roles of pol zeta in TLS and cell cycle control might contribute to mouse embryonic lethality.

Translesion Synthesis By Yeast Dna Polymerase Zeta From Templates Containing Lesions Of Ultraviolet Radiation And Acetylaminofluorene

Dna Polymerase Zeta: New Insight Into Eukaryotic Mutagenesis And Mammalian Embryonic Development

DNA polymerase ζ is a robust reverse transcriptase

Error-prone Lesion Bypass by Human DNA Polymerase Eta

Lesion bypass activities of human DNA polymerase mu.

Bypass of DNA interstrand crosslinks by a Rev1-DNA polymerase ζ complex

Error-free and error-prone lesion bypass by human DNA polymerase κ in vitro

DNA polymerase Zeta is a robust reverse transcriptase

Structure and Mechanism of Human DNA Polymerase Η

A human high-fidelity DNA polymerase holoenzyme has a wide range of lesion bypass activities

Response of Human Rev1 to Different Dna Damage: Preferential Dcmp Insertion Opposite the Lesion

Pre-steady-state kinetic investigation of bypass of a bulky guanine lesion by human Y-family DNA polymerases

DNA Polymerase η Promotes the Transcriptional Bypass of N 2 -Alkyl-2′-deoxyguanosine Adducts in Human Cells

Activities of human DNA polymerase κ in response to the major benzo[a]pyrene DNA adduct: error-free lesion bypass and extension synthesis from opposite the lesion

A hand-off of DNA between archaeal polymerases allows high-fidelity replication to resume at a discrete intermediate three bases past 8-oxoguanine

Catalytic and noncatalytic functions of DNA polymerase κ in translesion DNA synthesis

Effects of Base Sequence Context on Translesion Synthesis Past a Bulky (+)-Trans-anti-b[a]p-n2-dg Lesion Catalyzed by the Y-family Polymerase Pol Kappa.

Effects of Base Sequence Context on Translesion Synthesis Past a Bulky (+)-trans-anti-B[a]P-N2-dG Lesion Catalyzed by the Y-family Polymerase pol κ†

Mechanism of genome instability mediated by human DNA polymerase mu misincorporation

Two-step Error-Prone Bypass of the (+)- and (−)-Trans-anti-bpde-n2-dg Adducts by Human DNA Polymerases Η and Κ

Post-replicative lesion processing limits DNA damage-induced mutagenesis